Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306)

PURPOSE: To assess the impact of primary tumor sidedness on outcome of patients with metastatic colorectal cancer (mCRC) across treatment lines. PATIENTS AND METHODS: Patients of the FIRE-3 trial (initial FOLFIRI plus either cetuximab or bevacizumab) were separately evaluated according to primary tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Modest, Dominik Paul, Stintzing, Sebastian, von Weikersthal, Ludwig Fischer, Decker, Thomas, Kiani, Alexander, Vehling-Kaiser, Ursula, Al-Batran, Salah-Eddin, Heintges, Tobias, Kahl, Christoph, Seipelt, Gernot, Kullmann, Frank, Scheithauer, Werner, Moehler, Markus, Holch, Julian Walter, von Einem, Jobst Christian, Held, Swantje, Heinemann, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739676/
https://www.ncbi.nlm.nih.gov/pubmed/29285289
http://dx.doi.org/10.18632/oncotarget.22396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739676/
https://www.ncbi.nlm.nih.gov/pubmed/29285289
http://dx.doi.org/10.18632/oncotarget.22396

Ejemplares similares